Pharmafile Logo

#RemoteDetailing

National Institute for Health and Care Excellence NICE logo

NICE backs five new drugs after discounts agreed

Includes Novartis’ previously rejected lung cancer and melanoma therapies Zykadia and Mekinist

- PMLiVE

X4 appoints John Celebi as COO

He joins from Igenica Biotherapeutics

- PMLiVE

Why train… millennials?

Do companies get a return on investment when they train millennials? 

- PMLiVE

BMS appoints Murdo Gordon as chief commercial officer

He also becomes executive vice president

- PMLiVE

UK marketing agency Purple opens Sao Paulo office

New location is the agency’s first in South America

- PMLiVE

Industry welcomes European diagnostics regulations

Trade bodies say they will support greater use of personalised medicines

- PMLiVE

Takeda starts trial of norovirus vaccine

If approved the drug is anticipated to surpass sales of GSK’s Rotarix vaccine

- PMLiVE

Circassia slumps as cat allergy vaccine fails late-stage trial

Has suspended several trials after an “unprecedented” placebo effect derailed leading drug candidate

- PMLiVE

Envigo appoints Patricia Henahan as chief financial officer

She brings experience from AZ, Eli Lilly and Hospira

- PMLiVE

Cost containment and the German market

The healthcare system’s budget limitations will face further pressure from challenges such as personalised medicine

- PMLiVE

Ogilvy & Mather’s ‘Breathless choir’ wins top pharma prize at Lions Health

FCB’s ‘Project literacy’ and DAVID’s ‘Manboobs’ also take home Grand Prix awards

- PMLiVE

Apple talks up health and fitness benefits of new Watch OS

Outlines new Breathe app and stronger fitness integration for watchOS 3

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links